Assessment of Pneumococcal Vaccination in Children as a Basis of Shared Decision-Making for Adults

Abstract

Get full access to this article

View all access options for this article.

References

Matanock

Lee

Gierke

, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2019;68:1069-1075.

Shah

Wallace

Fields

. Shared decision-making for administering PCV13 in older adults. Am Fam Physician. 2020;101:134-135.

Hill

Elam-Evans

Yankey

Singleton

Dietz

. Vaccination coverage among children aged 19-35 months—United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67:1123-1128.

Centers for Disease Control and Prevention. 2017 Childhood pneumococcal conjugate vaccine (PCV) coverage report. Accessed March 3, 2020. https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/data-reports/pcv/reports/2017.html